4//SEC Filing
SEIDENBERG BETH C 4
Accession 0001104659-25-058225
CIK 0001400118other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 5:42 PM ET
Size
8.0 KB
Accession
0001104659-25-058225
Insider Transaction Report
Form 4
SEIDENBERG BETH C
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-06+28,522→ 28,522 totalExercise: $5.56Exp: 2035-06-05→ Series A Common Stock (28,522 underlying) - Award
Stock Option (Right to Buy)
2025-06-09+32,250→ 32,250 totalExercise: $5.33Exp: 2035-06-08→ Series A Common Stock (32,250 underlying)
Footnotes (2)
- [F1]The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 6, 2025, subject to the Reporting Person's continued service on each such vesting date.
- [F2]The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 9, 2025, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Sagimet Biosciences Inc.
CIK 0001400118
Entity typeother
Related Parties
1- filerCIK 0001184592
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 5:42 PM ET
- Size
- 8.0 KB